Utility of Video Consultation in Digestive Diseases

Main Article Content

Modesto Varas Lorenzo Tania Navas Serra César Morcillo Serra

Abstract

Introduction: Despite the rise of video consultation, most consultations in patients with digestive diseases tend to be face-to-face.


 Objective and Methods: In 2016, gastroenterology video consultation was implemented in the hospital. A prospective and descriptive study of a series of patients attended consecutively by video consultation by a gastroenterology specialist for 50 months. We have analyzed which syndromes and digestive diseases are susceptible to being performed by video consultation.


Results: Two hundred fifty patients were selected (100 during the first three months of the COVID-19 pandemic), 50.4% men and 49.6% women, with a mean age of 48 (SD 18-9) years. The main reason for the consultation of the 142 patients (56.8%) with definitive diagnoses was: dyspepsia, hepatobiliary disease, diarrhea, gastroesophageal reflux, and irritable bowel syndrome. The final diagnosis was dyspepsia (21%), hepatobiliary disease (16%), diarrhea (9%), irritable bowel syndrome (8.4%), intolerances (including gluten intolerance and sensitivity) (8.4%), gastroesophageal reflux disease (7,7%), and inflammatory bowel disease (6.3%). The concordance between the diagnostic impression and the definitive diagnosis was 60%.


 Conclusions: Video consultation in gastroenterology is an effective alternative to the face-to-face visit, used equally in patients of both sexes, where dyspepsia is the main reason for consultation and diagnosis. During the first 3 months of the COVID-19 pandemic, the number of video consultations increased 10 times. The main pathologies diagnosed were dyspepsia and hepatobiliary diseases.

Article Details

How to Cite
LORENZO, Modesto Varas; SERRA, Tania Navas; SERRA, César Morcillo. Utility of Video Consultation in Digestive Diseases. Medical Research Archives, [S.l.], v. 8, n. 12, dec. 2020. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/2292>. Date accessed: 24 jan. 2021. doi: https://doi.org/10.18103/mra.v8i12.2292.
Section
Research Articles

References

1. Morcillo C, González JL. Nuevas tecnologías digitales en la práctica médica. Med Clin Barc 2020;154,20-22. https://doi.org/10.1016/j.medcli.2019.07.004.
2. Tuckson RV, Edmunds M, Hodgkins ML. Telehealth. N Engl J Med 2017; 377,1585-1592.
3. Zambrana-García JL, Montoro MI, Chicano M, et al. Eficacia de un sistema de consultas de alta resolución en gastroenterología en un centro hospitalario andaluz. Rev Esp Enferm Dig 2016; 108: 3-7.
4. Kane CK, Gillis K. Use of Telemedicine by physicians. Healt Aff 2018; 37: 1923-30.
5. Cross RK, Kane S. Integration of telemedicine into clinical gastroentrology and hepatology practice. Clin Gastroenterol Hepatol 2017; 15: 175-81.
6. Torrejón A, Masachs M, Borruel N et al. Aplicación de un modelo de asistencia continuada en la enfermedad inflamatoria intestinal: la unidad de atención Crohn-Colitis. Gastroentrol y Hepatol 2009; 32: 77-82.
7. Krier M, Kaltenbach T, McQuaid K, et al. Potential use of Telemedicine to provide outpatient care for IBD. Scand J Gastroenterol 2011; 106: 2063-7.
8. Huang VW, Reich KM, Fedorak RN. Distance mnagement of Inflammatory Bowel Disease: systematic review and meta-analysis. World J Gastroenterol 2014; 20: 829-42.
9. De Jong MJ, Van der Meulen-De Jong AE, Romberg-Camps MJ, et al. Telemedicine for management of inflammatory bowel disease (myIBDoach): a pragmatic, multicentre, randomized controlled trial. Lancet 2017; 390: 959-68.
10. Cross RK, Langenberg P, Regueiro M et al. A randomized controlled trial of telemedicine for patients with inflammatory bowel disease (TELE-IBD). Am J Gastroenterol 2019; 114: 472-82.
11. Del.Hoyo J, Nos P, Bastida G et al. Telemonitorización de la enfermedad de Crohn y la colitis ulcerosa (TECCU): análisis de coste-efectividad. J Med Internet Res 2019; 21: e15505.
12. Stotts MJ, Crischkan JA, Khungar V. Improving cirrosis care: the potential for telemedicine amd mobile health technologies. World J Gastroenterol 2019; 25: 3849-56.
13. Mauro E, Marciano S, Torres MC et al. Telemedicine improves access to hepatology consultation with high patient satisfaction. J Clin Experimental Hepatol 2020. In Press. https://doi.org/10.1016/j.jceh.2020.04.017
14. Editorial. The potential of Telemedicine in digestive diseases. Lancet Gastroentero Hepatol 2019; 4: 185.
15. Arora S. Project ECHO. Democratising knowledge for the elimination of viral hepatitis. Lancet Gastroenterol Hepatol 2019; 4: 91-3.
16. Helsel BC, Williams JE, Lawson K et al. Systematic review of Telemedicine in digestive diseases. Dig Dis Sci 2018; 63: 1392-1408.
17. Lee T, Kim L. Telemedicine in gastroenterology: A value added service of patients. Clin Gastroenterol Hepatol 2020; 18: 530-3.
18. Song X, liu X, Wang C. The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province. Critical Care 2020; 24: 178-81.
19. Huntzinger M, Bielefeldt K. Expanding the scope of Telemedicine in Gastroenterology. Fed Pract 2018; 35: 26-31.
20. Morcillo C, Tizon D, Marzal D, Tomás JF. Digital health solutions implemented by Sanitas hospitals to maintain continuity of care during COVID-19 pandemic. Medical Research Archives, [S.l.], v. 8, n. 8, aug. 2020. ISSN 2375-1924. https://doi.org/10.18103/mra.v8i8.2228
21. Alvarez PE, Castiblanco F, Correa AF y cols. Covid-19, médicos, gastroenterología y emociones. Rev Colombiana de Gastroenterología 2020; 35 (Supl 1): 64-68.
22. Serper M, Cubell AW, Deleener ME et al. Telemedicine in liver disease beyond: Can the COVID-19 crisis lead to action? Hepatology 2020; 72: 723-728 doi: 10.1002/hep.31276.

Most read articles by the same author(s)

Obs.: This plugin requires at least one statistics/report plugin to be enabled. If your statistics plugins provide more than one metric then please also select a main metric on the admin's site settings page and/or on the journal manager's settings pages.